Skip to content

App development is a golden opportunity - but pharma companies need to be wary

Liz Ashall-Payne, founding CEO of digital health consultancy ORCHA assesses the pharma's potential for digital apps and what the industry needs to bear in mind.

App development is a golden opportunity - but pharma companies need to be wary
Published: | 3 min read

Liz Ashall-Payne, founding CEO of digital health consultancy ORCHA assesses pharma's potential for digital apps and what the industry needs to bear in mind.

Since Covid-19 arrived, there has been a 25% rise in health app downloads, up from 4 to 5 million every day.  There has also been a 6,500% increase in healthcare professionals recommending apps to patients. Health tech experts acknowledge that the sector has advanced five years in the last 18 months.

Given this bow wave in enthusiasm for digital, it would seem logical for pharma to embrace what seems like a golden opportunity to engage with patients.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information